Zur Kurzanzeige

dc.contributor.authorGerboth, S.
dc.contributor.authorFrittoli, E.
dc.contributor.authorPalamiessi, A.
dc.contributor.authorBaltanas, F. C.
dc.contributor.authorSalek, M.
dc.contributor.authorRappsilber, J.
dc.contributor.authorGiuliani, C.
dc.contributor.authorTroglio, F.
dc.contributor.authorRolland, Y.
dc.contributor.authorPruneri, G.
dc.contributor.authorKreutmair, S.
dc.contributor.authorPallavicini, I.
dc.contributor.authorZobel, M.
dc.contributor.authorCinquanta, M.
dc.contributor.authorMinucci, S.
dc.contributor.authorGómez Rodríguez, Carmela 
dc.contributor.authorSantos de Dios, Eugenio Miguel 
dc.contributor.authorIllert, A. L.
dc.contributor.authorScita, G.
dc.date.accessioned2026-02-11T09:34:38Z
dc.date.available2026-02-11T09:34:38Z
dc.date.issued2017
dc.identifier.citationGerboth, Frittoli, Palamidessi, Baltanas, Salek, Rappsilber, Giuliani, Troglio, Rolland, Pruneri, Kreutmair, Pallavicini, Zobel, Cinquanta, Minucci, Gomez, Santos, Illert, & Scita. (2018). Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis. Leukemia, 32(3), 820-827. https://doi.org/10.1038/LEU.2017.267es_ES
dc.identifier.issn0887-6924
dc.identifier.urihttp://hdl.handle.net/10366/169720
dc.description.abstract[EN]Son of Sevenless 1 (SOS1) is a dual guanine nucleotide exchange factor (GEF) that activates the small GTPases RAC and RAS. Although the molecular mechanisms of RAS GEF catalysis have been unveiled, how SOS1 acquires RAC GEF activity and what is the physio-pathological relevance of this activity is much less understood. Here we show that SOS1 is tyrosine phosphorylated on Y1196 by ABL. Phosphorylation of Y1196 controls SOS1 inter-molecular interaction, is required to promote the exchange of nucleotides on RAC in vitro and for platelet-derived growth factor (PDGF) activation of RAC- and RAC-dependent actin remodeling and cell migration. SOS1 is also phosphorylated on Y1196 by BCR-ABL in chronic myelogenous leukemic cells. Importantly, in these cells, SOS1 is required for BCR-ABL-mediated activation of RAC, cell proliferation and transformation in vitro and in a xenograft mouse model. Finally, genetic removal of Sos1 in the bone marrow-derived cells (BMDCs) from Sos1fl/fl mice and infected with BCR-ABL causes a significant delay in the onset of leukemogenesis once BMDCs are injected into recipient, lethally irradiated mice. Thus, SOS1 is required for full transformation and critically contribute to the leukemogenic potential of BCR-ABL.es_ES
dc.language.isoenges_ES
dc.publisherSpringer Naturees_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectSOS1es_ES
dc.subjectCMLes_ES
dc.subjectBCR-ABLes_ES
dc.titlePhosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1038/LEU.2017.267es_ES
dc.identifier.doi10.1038/leu.2017.267
dc.relation.projectIDInternational Association For Cancer Research (AICR-09-0582 and 14-0335)es_ES
dc.relation.projectIDEuropean Research Council (Advanced-ERC268836)es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccesses_ES
dc.identifier.essn1476-5551
dc.journal.titleLeukemiaes_ES
dc.volume.number32es_ES
dc.issue.number3es_ES
dc.page.initial820es_ES
dc.page.final827es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: Attribution-NonCommercial-NoDerivatives 4.0 Internacional